Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

A Single-Dose Recombinant Parainfluenza Virus 5-Vectored Vaccine Expressing Respiratory Syncytial Virus (RSV) F or G Protein Protected Cotton Rats and African Green Monkeys from RSV Challenge.

Wang D, Phan S, DiStefano DJ, Citron MP, Callahan CL, Indrawati L, Dubey SA, Heidecker GJ, Govindarajan D, Liang X, He B, Espeseth AS.

J Virol. 2017 May 12;91(11). pii: e00066-17. doi: 10.1128/JVI.00066-17. Print 2017 Jun 1.

2.

Influenza hemagglutinin stem-fragment immunogen elicits broadly neutralizing antibodies and confers heterologous protection.

Mallajosyula VV, Citron M, Ferrara F, Lu X, Callahan C, Heidecker GJ, Sarma SP, Flynn JA, Temperton NJ, Liang X, Varadarajan R.

Proc Natl Acad Sci U S A. 2014 Jun 24;111(25):E2514-23. doi: 10.1073/pnas.1402766111. Epub 2014 Jun 9.

3.

Structural determinants of human APOBEC3A enzymatic and nucleic acid binding properties.

Mitra M, Hercík K, Byeon IJ, Ahn J, Hill S, Hinchee-Rodriguez K, Singer D, Byeon CH, Charlton LM, Nam G, Heidecker G, Gronenborn AM, Levin JG.

Nucleic Acids Res. 2014 Jan;42(2):1095-110. doi: 10.1093/nar/gkt945. Epub 2013 Oct 24.

4.

Cell-to-cell transmission can overcome multiple donor and target cell barriers imposed on cell-free HIV.

Zhong P, Agosto LM, Ilinskaya A, Dorjbal B, Truong R, Derse D, Uchil PD, Heidecker G, Mothes W.

PLoS One. 2013;8(1):e53138. doi: 10.1371/journal.pone.0053138. Epub 2013 Jan 7.

5.

Cell-cell transmission allows human T-lymphotropic virus 1 to circumvent tetherin restriction.

Ilinskaya A, Derse D, Hill S, Princler G, Heidecker G.

Virology. 2013 Feb 5;436(1):201-9. doi: 10.1016/j.virol.2012.11.012. Epub 2012 Dec 20.

6.

Design of Escherichia coli-expressed stalk domain immunogens of H1N1 hemagglutinin that protect mice from lethal challenge.

Bommakanti G, Lu X, Citron MP, Najar TA, Heidecker GJ, ter Meulen J, Varadarajan R, Liang X.

J Virol. 2012 Dec;86(24):13434-44. doi: 10.1128/JVI.01429-12. Epub 2012 Sep 26.

7.

A reporter system for replication-competent gammaretroviruses: the inGluc-MLV-DERSE assay.

Aloia AL, Duffy L, Pak V, Lee KE, Sanchez-Martinez S, Derse D, Heidecker G, Cornetta K, Rein A.

Gene Ther. 2013 Feb;20(2):169-76. doi: 10.1038/gt.2012.18. Epub 2012 Mar 8.

8.

Role of O-glycosylation and expression of CD43 and CD45 on the surfaces of effector T cells in human T cell leukemia virus type 1 cell-to-cell infection.

Mazurov D, Ilinskaya A, Heidecker G, Filatov A.

J Virol. 2012 Mar;86(5):2447-58. doi: 10.1128/JVI.06993-11. Epub 2011 Dec 14.

9.

The role of ITCH protein in human T-cell leukemia virus type 1 release.

Dorjbal B, Derse D, Lloyd P, Soheilian F, Nagashima K, Heidecker G.

J Biol Chem. 2011 Sep 9;286(36):31092-104. doi: 10.1074/jbc.M111.259945. Epub 2011 Jul 1.

10.

The role of amino-terminal sequences in cellular localization and antiviral activity of APOBEC3B.

Pak V, Heidecker G, Pathak VK, Derse D.

J Virol. 2011 Sep;85(17):8538-47. doi: 10.1128/JVI.02645-10. Epub 2011 Jun 29.

11.

Interaction between the HTLV-1 envelope and cellular proteins: impact on virus infection and restriction.

Ilinskaya A, Heidecker G, Jones K.

Future Med Chem. 2010 Nov;2(11):1651-68. doi: 10.4155/fmc.10.255. Review.

PMID:
21428837
12.
13.

Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge.

Bommakanti G, Citron MP, Hepler RW, Callahan C, Heidecker GJ, Najar TA, Lu X, Joyce JG, Shiver JW, Casimiro DR, ter Meulen J, Liang X, Varadarajan R.

Proc Natl Acad Sci U S A. 2010 Aug 3;107(31):13701-6. doi: 10.1073/pnas.1007465107. Epub 2010 Jul 6.

14.

Opposing effects of a tyrosine-based sorting motif and a PDZ-binding motif regulate human T-lymphotropic virus type 1 envelope trafficking.

Ilinskaya A, Heidecker G, Derse D.

J Virol. 2010 Jul;84(14):6995-7004. doi: 10.1128/JVI.01853-09. Epub 2010 May 12.

15.

Quantitative comparison of HTLV-1 and HIV-1 cell-to-cell infection with new replication dependent vectors.

Mazurov D, Ilinskaya A, Heidecker G, Lloyd P, Derse D.

PLoS Pathog. 2010 Feb 26;6(2):e1000788. doi: 10.1371/journal.ppat.1000788.

16.

Efficacy of multivalent adenovirus-based vaccine against simian immunodeficiency virus challenge.

Casimiro DR, Cox K, Tang A, Sykes KJ, Feng M, Wang F, Bett A, Schleif WA, Liang X, Flynn J, Tobery TW, Wilson K, Finnefrock A, Huang L, Vitelli S, Lin J, Patel D, Davies ME, Heidecker GJ, Freed DC, Dubey S, O'Connor DH, Watkins DI, Zhang ZQ, Shiver JW.

J Virol. 2010 Mar;84(6):2996-3003. doi: 10.1128/JVI.00969-09. Epub 2009 Dec 30.

17.

Robust, vaccine-induced CD8(+) T lymphocyte response against an out-of-frame epitope.

Maness NJ, Wilson NA, Reed JS, Piaskowski SM, Sacha JB, Walsh AD, Thoryk E, Heidecker GJ, Citron MP, Liang X, Bett AJ, Casimiro DR, Watkins DI.

J Immunol. 2010 Jan 1;184(1):67-72. doi: 10.4049/jimmunol.0903118. Epub 2009 Nov 30.

18.

Assembly of the murine leukemia virus is directed towards sites of cell-cell contact.

Jin J, Sherer NM, Heidecker G, Derse D, Mothes W.

PLoS Biol. 2009 Jul;7(7):e1000163. doi: 10.1371/journal.pbio.1000163. Epub 2009 Jul 28.

19.

Vaccine-induced cellular responses control simian immunodeficiency virus replication after heterologous challenge.

Wilson NA, Keele BF, Reed JS, Piaskowski SM, MacNair CE, Bett AJ, Liang X, Wang F, Thoryk E, Heidecker GJ, Citron MP, Huang L, Lin J, Vitelli S, Ahn CD, Kaizu M, Maness NJ, Reynolds MR, Friedrich TC, Loffredo JT, Rakasz EG, Erickson S, Allison DB, Piatak M Jr, Lifson JD, Shiver JW, Casimiro DR, Shaw GM, Hahn BH, Watkins DI.

J Virol. 2009 Jul;83(13):6508-21. doi: 10.1128/JVI.00272-09. Epub 2009 Apr 29.

20.

Anti-ADDL antibodies differentially block oligomer binding to hippocampal neurons.

Shughrue PJ, Acton PJ, Breese RS, Zhao WQ, Chen-Dodson E, Hepler RW, Wolfe AL, Matthews M, Heidecker GJ, Joyce JG, Villarreal SA, Kinney GG.

Neurobiol Aging. 2010 Feb;31(2):189-202. doi: 10.1016/j.neurobiolaging.2008.04.003.

PMID:
18486276
21.

The role of WWP1-Gag interaction and Gag ubiquitination in assembly and release of human T-cell leukemia virus type 1.

Heidecker G, Lloyd PA, Soheilian F, Nagashima K, Derse D.

J Virol. 2007 Sep;81(18):9769-77. Epub 2007 Jul 3.

22.

Resistance of human T cell leukemia virus type 1 to APOBEC3G restriction is mediated by elements in nucleocapsid.

Derse D, Hill SA, Princler G, Lloyd P, Heidecker G.

Proc Natl Acad Sci U S A. 2007 Feb 20;104(8):2915-20. Epub 2007 Feb 13.

23.

The inner loop of tetraspanins CD82 and CD81 mediates interactions with human T cell lymphotrophic virus type 1 Gag protein.

Mazurov D, Heidecker G, Derse D.

J Biol Chem. 2007 Feb 9;282(6):3896-903. Epub 2006 Dec 13.

24.

HTLV-1 Gag protein associates with CD82 tetraspanin microdomains at the plasma membrane.

Mazurov D, Heidecker G, Derse D.

Virology. 2006 Mar 1;346(1):194-204. Epub 2005 Dec 1.

25.

Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with dna and recombinant adenoviral vaccine vectors expressing Gag.

Casimiro DR, Wang F, Schleif WA, Liang X, Zhang ZQ, Tobery TW, Davies ME, McDermott AB, O'Connor DH, Fridman A, Bagchi A, Tussey LG, Bett AJ, Finnefrock AC, Fu TM, Tang A, Wilson KA, Chen M, Perry HC, Heidecker GJ, Freed DC, Carella A, Punt KS, Sykes KJ, Huang L, Ausensi VI, Bachinsky M, Sadasivan-Nair U, Watkins DI, Emini EA, Shiver JW.

J Virol. 2005 Dec;79(24):15547-55.

26.

Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.

Liang X, Casimiro DR, Schleif WA, Wang F, Davies ME, Zhang ZQ, Fu TM, Finnefrock AC, Handt L, Citron MP, Heidecker G, Tang A, Chen M, Wilson KA, Gabryelski L, McElhaugh M, Carella A, Moyer C, Huang L, Vitelli S, Patel D, Lin J, Emini EA, Shiver JW.

J Virol. 2005 Oct;79(19):12321-31.

27.

Infectious transmission and replication of human T-cell leukemia virus type 1.

Derse D, Heidecker G, Mitchell M, Hill S, Lloyd P, Princler G.

Front Biosci. 2004 Sep 1;9:2495-9. Review.

PMID:
15353302
28.

Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys.

Fan J, Liang X, Horton MS, Perry HC, Citron MP, Heidecker GJ, Fu TM, Joyce J, Przysiecki CT, Keller PM, Garsky VM, Ionescu R, Rippeon Y, Shi L, Chastain MA, Condra JH, Davies ME, Liao J, Emini EA, Shiver JW.

Vaccine. 2004 Aug 13;22(23-24):2993-3003.

PMID:
15297047
29.

Late assembly motifs of human T-cell leukemia virus type 1 and their relative roles in particle release.

Heidecker G, Lloyd PA, Fox K, Nagashima K, Derse D.

J Virol. 2004 Jun;78(12):6636-48.

30.

Activation of interleukin-13 expression in T cells from HTLV-1-infected individuals and in chronically infected cell lines.

Chung HK, Young HA, Goon PK, Heidecker G, Princler GL, Shimozato O, Taylor GP, Bangham CR, Derse D.

Blood. 2003 Dec 1;102(12):4130-6. Epub 2003 Aug 14.

31.

Comparative immunogenicity in rhesus monkeys of DNA plasmid, recombinant vaccinia virus, and replication-defective adenovirus vectors expressing a human immunodeficiency virus type 1 gag gene.

Casimiro DR, Chen L, Fu TM, Evans RK, Caulfield MJ, Davies ME, Tang A, Chen M, Huang L, Harris V, Freed DC, Wilson KA, Dubey S, Zhu DM, Nawrocki D, Mach H, Troutman R, Isopi L, Williams D, Hurni W, Xu Z, Smith JG, Wang S, Liu X, Guan L, Long R, Trigona W, Heidecker GJ, Perry HC, Persaud N, Toner TJ, Su Q, Liang X, Youil R, Chastain M, Bett AJ, Volkin DB, Emini EA, Shiver JW.

J Virol. 2003 Jun;77(11):6305-13.

32.

Virology. Forced entry--or does HTLV-I have the key?

Derse D, Heidecker G.

Science. 2003 Mar 14;299(5613):1670-1. No abstract available.

PMID:
12637723
34.

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity.

Shiver JW, Fu TM, Chen L, Casimiro DR, Davies ME, Evans RK, Zhang ZQ, Simon AJ, Trigona WL, Dubey SA, Huang L, Harris VA, Long RS, Liang X, Handt L, Schleif WA, Zhu L, Freed DC, Persaud NV, Guan L, Punt KS, Tang A, Chen M, Wilson KA, Collins KB, Heidecker GJ, Fernandez VR, Perry HC, Joyce JG, Grimm KM, Cook JC, Keller PM, Kresock DS, Mach H, Troutman RD, Isopi LA, Williams DM, Xu Z, Bohannon KE, Volkin DB, Montefiori DC, Miura A, Krivulka GR, Lifton MA, Kuroda MJ, Schmitz JE, Letvin NL, Caulfield MJ, Bett AJ, Youil R, Kaslow DC, Emini EA.

Nature. 2002 Jan 17;415(6869):331-5.

PMID:
11797011
35.

Vaccine-induced immune responses in rodents and nonhuman primates by use of a humanized human immunodeficiency virus type 1 pol gene.

Casimiro DR, Tang A, Perry HC, Long RS, Chen M, Heidecker GJ, Davies ME, Freed DC, Persaud NV, Dubey S, Smith JG, Havlir D, Richman D, Chastain MA, Simon AJ, Fu TM, Emini EA, Shiver JW.

J Virol. 2002 Jan;76(1):185-94.

36.

An enhanced and scalable process for the purification of SIV Gag-specific MHC tetramer.

Grimm KM, Trigona WL, Heidecker GJ, Joyce JG, Fu TM, Shiver JW, Keller PM, Cook JC.

Protein Expr Purif. 2001 Nov;23(2):270-81.

PMID:
11676602
37.

Interleukin-6 regulation of the human DNA methyltransferase (HDNMT) gene in human erythroleukemia cells.

Hodge DR, Xiao W, Clausen PA, Heidecker G, Szyf M, Farrar WL.

J Biol Chem. 2001 Oct 26;276(43):39508-11. Epub 2001 Sep 10.

38.

Caenorhabditis elegans contains a third polo-like kinase gene.

Chase D, Golden A, Heidecker G, Ferris DK.

DNA Seq. 2000;11(3-4):327-34.

PMID:
11092748
39.

Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys.

Barouch DH, Craiu A, Kuroda MJ, Schmitz JE, Zheng XX, Santra S, Frost JD, Krivulka GR, Lifton MA, Crabbs CL, Heidecker G, Perry HC, Davies ME, Xie H, Nickerson CE, Steenbeke TD, Lord CI, Montefiori DC, Strom TB, Shiver JW, Lewis MG, Letvin NL.

Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):4192-7.

40.

Macaques infected with cloned simian immunodeficiency virus show recurring nef gene alterations.

Heidecker G, Muñoz H, Lloyd P, Hodge D, Ruscetti FW, Morton WR, Hu S, Benveniste RE.

Virology. 1998 Sep 30;249(2):260-74.

41.

Sequence diversity of SIV(Mne) Nef in vivo and in vitro.

Heidecker G, Muñoz H, Lloyd PA, Hodge DR, Pei GK, Rick SW, Brehm K, Ruscetti FW, Kuller L, Polacino P, Hu SL, Morton WR, Benveniste RE.

J Med Primatol. 1998 Apr-Jun;27(2-3):73-80.

PMID:
9747946
42.

Binding of c-Raf1 kinase to a conserved acidic sequence within the carboxyl-terminal region of the HIV-1 Nef protein.

Hodge DR, Dunn KJ, Pei GK, Chakrabarty MK, Heidecker G, Lautenberger JA, Samuel KP.

J Biol Chem. 1998 Jun 19;273(25):15727-33.

43.

Nontypeable Haemophilus influenzae susceptibility: effect of inoculum size and beta-lactamase production.

Gould JM, Heidecker GJ, LiPuma JJ.

Diagn Microbiol Infect Dis. 1996 Oct;26(2):95-8.

PMID:
8985663
44.

Survival of Burkholderia cepacia on environmental surfaces.

Drabick JA, Gracely EJ, Heidecker GJ, LiPuma JJ.

J Hosp Infect. 1996 Apr;32(4):267-76.

PMID:
8744511
45.

The effect of c-raf antisense oligonucleotides on growth factor-induced proliferation of hematopoietic cells.

Keller JR, Ruscetti FW, Heidecker G, Linnekin DM, Rapp U, Troppmair J, Gooya J, Muszynski KW.

Curr Top Microbiol Immunol. 1996;211:43-53. Review.

PMID:
8585963
46.

Detection of Pseudomonas (Burkholderia) cepacia using PCR.

Campbell PW 3rd, Phillips JA 3rd, Heidecker GJ, Krishnamani MR, Zahorchak R, Stull TL.

Pediatr Pulmonol. 1995 Jul;20(1):44-9.

PMID:
7478781
47.

Raf-1 protein is required for growth factor-induced proliferation of hematopoietic cells.

Muszynski KW, Ruscetti FW, Heidecker G, Rapp U, Troppmair J, Gooya JM, Keller JR.

J Exp Med. 1995 Jun 1;181(6):2189-99.

48.

Construction of an ori cassette for adapting shuttle vectors for use in Haemophilus influenzae.

Heidecker GJ, Pozsgay JM, Stull TL.

Gene. 1994 Dec 2;150(1):141-4.

PMID:
7959040
49.

Mechanism of inhibition of Raf-1 by protein kinase A.

Häfner S, Adler HS, Mischak H, Janosch P, Heidecker G, Wolfman A, Pippig S, Lohse M, Ueffing M, Kolch W.

Mol Cell Biol. 1994 Oct;14(10):6696-703.

50.

Enzymatic characteristics of the c-Raf-1 protein kinase.

Force T, Bonventre JV, Heidecker G, Rapp U, Avruch J, Kyriakis JM.

Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1270-4.

Supplemental Content

Loading ...
Support Center